
Sign up to save your podcasts
Or


Today's hip edition covers four compelling studies examining total hip arthroplasty outcomes, fracture recovery predictors, healthcare system performance, and mortality biomarkers. We explore dual-mobility versus conventional implants in ankylosing spondylitis patients, the role of inflammatory markers in predicting functional recovery after hip fracture, Greece's first national hip fracture registry findings, and a novel biomarker for risk stratification in femoral fracture patients.
By Joint Venture OrthopaedicsToday's hip edition covers four compelling studies examining total hip arthroplasty outcomes, fracture recovery predictors, healthcare system performance, and mortality biomarkers. We explore dual-mobility versus conventional implants in ankylosing spondylitis patients, the role of inflammatory markers in predicting functional recovery after hip fracture, Greece's first national hip fracture registry findings, and a novel biomarker for risk stratification in femoral fracture patients.